Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tubulin polymerization-IN-45, a tubulin-targeting agent, acts as a tubulin polymerization inhibitor by binding to the tubulin's colchicine site. It induces apoptotic cell death in hepatocellular cancer (HCC) cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Tubulin polymerization-IN-45, a tubulin-targeting agent, acts as a tubulin polymerization inhibitor by binding to the tubulin's colchicine site. It induces apoptotic cell death in hepatocellular cancer (HCC) cells [1]. |
In vitro | Tubulin polymerization-IN-45 (compound 18) demonstrates effective activity against hepatocellular carcinoma (HCC) cell lines, with IC50 values ranging from 0.6 to 2.9 μM. It also exhibits moderate inhibitory activity on microtubule polymerization (IC50 = 19 μM). Furthermore, Tubulin polymerization-IN-45 causes cell cycle arrest at the G2/M phase in Huh7 and Mahlavu cells and induces apoptosis in HCC cells [1]. |
Molecular Weight | 362.38 |
Formula | C20H18N4O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tubulin polymerization-IN-45 inhibitor inhibit